>_ QFI Terminal
TerminalStocks › PRPH

ProPhase Labs, Inc. (PRPH) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.07 -27.56%
Last updated Jun 18, 2026 23:51 UTC

PRPH Key Statistics

Market Cap$342,485.61
P/E (TTM)0.00
P/S (TTM)0.32
P/B (TTM)0.04
Revenue (TTM)$1.08M
EPS (TTM)$-16.40
Dividend Yield
ROE (TTM)-404.42%
Net Margin-3,872.24%
Gross Margin191.36%
52W High$0.19
52W Low$0.07
Analyst ViewBuy
Price Target$140.00
Employees96
Volume68,532

About ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

CEO: Ted William Karkus. Company website

See PRPH live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open PRPH in Terminal See plans

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corporation MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.